LP
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes | Transplant international | 2022 | 370 | 149 | |||
402.7: Homemade hydrogel from human amniotic membrane improves islet transplantation outcomes in diabetic immunodeficient mice | Transplantation | 2021 | 170 | 2 | |||
P.169: Decellularized cotyledons isolated from human placenta used like a scaffold for the generation of a human bioartificial pancreas | Transplantation | 2021 | 131 | 1 | |||
Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells | Stem cell reviews and reports | 2021 | 208 | 112 | |||
402.5: Human Amniotic Epithelial Cells Immunomodulatory Properties Protect Islets Against Inflammatory Cytokines In Vitro | Transplantation | 2021 | 151 | 1 | |||
Engineering of primary pancreatic islet cell spheroids for three-dimensional culture or transplantation: a methodological comparative study | Cell Transplantation | 2020 | 334 | 169 | |||
Shielding islets with human amniotic epithelial cells enhances islet engraftment and revascularization in a murine diabetes model | American Journal of Transplantation | 2020 | 249 | 151 | |||
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes | Nature Communications | 2019 | 345 | 223 |